AI Drug Firm METiS Considering $200 Million Hong Kong IPO, Sources Say

(Bloomberg) -- Artificial intelligence-driven drug firm METiS Pharmaceuticals is considering an initial public offering in Hong Kong to raise as much as $200 million, according to people familiar with the matter.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsIs Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?What’s Behind the Rise in Serious Injuries on New York City’s Street